Nanobiotix

Nanobiotix Dividend Coverage

Dividend Coverage Ratio of Nanobiotix (NBTX) as of Oct 27, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of Nanobiotix is 2026 - . Dividend Coverage Ratio of Nanobiotix was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nanobiotix Stock analysis

What does Nanobiotix do? Nanobiotix, based in Paris, France, is a clinical-stage biotechnology company focused on developing innovative treatments for cancer and unmet medical needs. Its lead product, NBTXR3, uses hafnium oxide nanoparticles to treat various cancers, including sarcoma and lung cancer. The company has a partnership with Lian Oncology for development and commercialization in Asia. Listed on the stock market in December 2020, Nanobiotix employs 97 people. Nanobiotix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nanobiotix stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Nanobiotix since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Nanobiotix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Nanobiotix

All Key Metrics — Nanobiotix